The document discusses the urethral route of drug administration and novel drug delivery systems. Specifically, it describes: 1) The urethral route involves inserting drugs like solutions or suppositories into the urethra to treat conditions like incontinence or impotence, but it can cause inconvenience or pain. 2) Alprostadil urethral microsuppositories are self-inserted drug delivery devices that are 1.4mm in diameter and release medication over 4-7 days. 3) Novel drug delivery systems aim to improve drug potency, provide sustained release, increase safety, and target specific tissues through formulation approaches and medical devices.